Hims Stock Surges After RFK Jr. Eases Access To Unapproved Peptides
A telehealth company's stock rose after regulatory approval restrictions on certain peptides were eased.· summarised by Stockedin
HIMS
HIMS · NYSE
Information, not investment advice.
A telehealth company's stock rose after regulatory approval restrictions on certain peptides were eased.· summarised by Stockedin
Headline and publisher summary only; full articles stay with the source.